MRUS Chart
See on advanced chart >
About
Merus N.V. was incorporated under the laws of the Netherlands on June 16, 2003.The company is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics. Their pipeline of full-length human bispecific antibody candidates,...
Read More
- HighlightA clinical-stage oncology company that developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®)
- ExchangeNASDAQ
- Listing Date05/19/2016
- Established Date06/16/2003
- Full-time Employees172
- AddressUppsalalaan 17 3584 CT Utrecht The Netherlands
- Tel31-30-2538800
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology